These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9681699)

  • 1. Cytokines and bioincompatibility.
    Gesualdo L; Pertosa G; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 1998 Jul; 13(7):1622-6. PubMed ID: 9681699
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 3. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
    Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bioincompatibility in dialysis morbidity and mortality.
    Lazarus JM; Owen WF
    Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial kidney: status of the art and new perspectives.
    Stefoni S; Cianciolo G; Colì L; Raimondi C; Dalmastri V; Donati G; Manna C; Grammatico F
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):111-2. PubMed ID: 12751828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioincompatible membranes place patients with acute renal failure at increased risk of infection.
    Schiffl H; Sitter T; Lang S; König A; Haider M; Held E
    ASAIO J; 1995; 41(3):M709-12. PubMed ID: 8573898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter five. Evaluation of toxicity potential of hemodialyzers.
    Klein E; Autian J; Bower JD; Buffaloe G; Centella LJ; Colton CK; Darby TD; Farrell PC; Holland FF; Kennedy RS; Lipps B; Mason R; Nolph KD; Villarroel F; Wathen RL
    Artif Organs; 1978 Aug; 2(3):284-92. PubMed ID: 708292
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of dialysis membranes.
    Salem M; Ivanovich P; Mujais S
    Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple in vitro test to evaluate biocompatibility of dialysis membranes.
    Vincent D; Charmes JP; Benzakour M; Gualde N; Rigaud M; Leroux-Robert C
    Nephrol Dial Transplant; 1989; 4(4):306-8. PubMed ID: 2502740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dialysis membranes in infection.
    Vanholder R; Van Loo A; Dhondt AM; Ringoir S
    Nephrol Dial Transplant; 1996; 11 Suppl 2():101-3. PubMed ID: 8804006
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialysis-related amyloidosis: importance of biocompatibility and age.
    Jadoul M
    Nephrol Dial Transplant; 1998; 13 Suppl 7():61-4. PubMed ID: 9870440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis-related bioincompatibility and adhesion molecules.
    Dhondt A; Vanholder R; Lameire N
    Int J Artif Organs; 1998 Sep; 21(9):501-5. PubMed ID: 9828053
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

  • 16. Can choice of dialyser membrane have a beneficial effect on HIV load in the HIV-infected dialysis patient?
    Fontana D; Schut R; Rabb H
    Nephrol Dial Transplant; 2002 Mar; 17(3):529-30. PubMed ID: 11865116
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: an appraisal of the evidence.
    Churchill DN
    Nephrol Dial Transplant; 1995; 10 Suppl 10():52-6. PubMed ID: 8825434
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 19. Age and dialysis-related amyloidosis.
    Baldrati L; Docci D; Tomidei G; Capponcini C; Neri L; Feletti C
    Nephron; 1994; 67(1):120. PubMed ID: 8052356
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin free hemodialysis using heparin coated hemophan.
    Mujais SK; Chimeh H
    ASAIO J; 1996; 42(5):M538-41. PubMed ID: 8944937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.